Show simple item record

AuthorAltarawneh, Heba N.
AuthorChemaitelly, Hiam
AuthorHasan, Mohammad R.
AuthorAyoub, Houssein H.
AuthorQassim, Suelen
AuthorAlMukdad, Sawsan
AuthorCoyle, Peter
AuthorYassine, Hadi M.
AuthorAl-Khatib, Hebah A.
AuthorBenslimane, Fatiha M.
AuthorAl-Kanaani, Zaina
AuthorAl-Kuwari, Einas
AuthorJeremijenko, Andrew
AuthorKaleeckal, Anvar H.
AuthorLatif, Ali N.
AuthorShaik, Riyazuddin M.
AuthorAbdul-Rahim, Hanan F.
AuthorNasrallah, Gheyath K.
AuthorAl-Kuwari, Mohamed G.
AuthorButt, Adeel A.
AuthorAl-Romaihi, Hamad E.
AuthorAl-Thani, Mohamed H.
AuthorAl-Khal, Abdullatif
AuthorBertollini, Roberto
AuthorTang, Patrick
AuthorAbu-Raddad, Laith J.
Available date2022-06-13T05:37:34Z
Publication Date2022-03-31
Publication NameNew England Journal of Medicine
Identifierhttp://dx.doi.org/10.1056/NEJMc2200133
CitationAltarawneh HN, Chemaitelly H, Hasan MR, Ayoub HH, Qassim S, AlMukdad S, Coyle P, Yassine HM, Al-Khatib HA, Benslimane FM, Al-Kanaani Z, Al-Kuwari E, Jeremijenko A, Kaleeckal AH, Latif AN, Shaik RM, Abdul-Rahim HF, Nasrallah GK, Al-Kuwari MG, Butt AA, Al-Romaihi HE, Al-Thani MH, Al-Khal A, Bertollini R, Tang P, Abu-Raddad LJ. Protection against the Omicron Variant from Previous SARS-CoV-2 Infection. N Engl J Med. 2022 Mar 31;386(13):1288-1290. doi: 10.1056/NEJMc2200133.
ISSN00284793
URIhttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85125264303&origin=inward
URIhttp://hdl.handle.net/10576/32089
AbstractNatural infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) elicits strong protection against reinfection with the B.1.1.7 (alpha),1,2 B.1.351 (beta),1 and B.1.617.2 (delta)3 variants. However, the B.1.1.529 (omicron) variant harbors multiple mutations that can mediate immune evasion. We estimated the effectiveness of previous infection in preventing symptomatic new cases caused by omicron and other SARS-CoV-2 variants in Qatar. In this study, we extracted data regarding coronavirus disease 2019 (Covid-19) laboratory testing, vaccination, clinical infection data, and related demographic details from the national SARS-CoV-2 databases, which include all results of polymerase-chain-reaction (PCR) testing, vaccinations, and hospitalizations and deaths for Covid-19 in Qatar since the start of the pandemic.
Languageen
PublisherMassachusetts Medical Society
SubjectSARS-CoV-2
Omicron Variant
COVID-19
TitleProtection against the omicron variant from previous SARS-CoV-2 infection
TypeOther
Pagination1288-1290
Issue Number13
Volume Number386
ESSN1533-4406
dc.accessType Open Access


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record